Table 1.

Clinic pathological variables of the patients included in this study

Item	Patient no.(n = 225)	%
Age at diagnosis (years)   ≤ 65   > 65	109 116	48.4 51.6
Tumor size (pT)  pT1  pT2  pT3  pT4  Not available	175 16 30 3 1	77.8 6.4 13.3 1.3 0.4
FIGO staging  I  II  III  IV  Not available	167 15 36 6 1	74.2 6.7 16.0 2.7 0.4
Grade  G1  G2  G3  Not available	127 77 20 1	56.4 34.2 8.9 0.4
Nodal status (pN) pN0 pN1 pNX	142 21 62	63.1 9.3 27.6
Metastases (pM)  pM0  pM1  pMX	109 5 111	48.4 2.2 49.3
Survival  Alive  Dead  Not available	93 132 0	41.3 58.7 0.0
Progression
None  At least one  Not available	180 45 0	80.0 20.0 0.0

pT: Tumor size (pT1: The cancer is found only in the uterus; pT2: The tumor has spread from the uterus to the cervical stroma but not to other parts of the body; pT3: The cancer has spread beyond the uterus, but it is still only in the pelvic area; pT4: The cancer has spread to the mucosa of the rectum or bladder). FIGO: classification of the International Federation of Gynecology and Obstetrics (FIGO I: The cancer is found only in the uterus; FIGO II: The tumor has spread from the uterus to the cervical stroma but not to other parts of the body; FIGO III: The cancer has spread beyond the uterus, but it is still only in the pelvic area; FIGO IV: The cancer has spread to the mucosa of the rectum or bladder or the cancer has spread to lymph nodes in the groin area, and/or it has spread to distant organs, such as the bones or lungs). pN: status regarding lymph node. pN0: histopathological lymphnodes without cancer infiltration. pN1: histopathological lymphnodes with cancer infiltration. pNX: no information about lymph nodes in the histopathological examination, due to missing lymph node sampling. pM: status regarding distant metastasis. pM0: histopathological examination without sign for distant metastasis. pM1: histopathological examination with sign for distant metastasis. pMX: no information about distant metastasis in the histopathological examination